Zurich Cementless Total Hip Replacement

website_squares.014

The main design objective of the KYON Zurich Cementless THR, a proprietary system of implants, instruments and a surgical technique for canine total hip replacement, was to provide for an immediate and indefinitely stable anchorage of the prosthetic components. Total hip replacement techniques fall into two categories: Cemented and Cementless. Cemented THR provides fine short term, but less satisfactory long term outcomes. Aseptic loosening, the most common reason for long term failure of THR, is responsible for 75% of revisions in human patients. Conventional press-fit cementless THR’s have taken about 50% of the market, but the revision rates in all categories of human patients remain higher than with cemented THR.[1] The femoral and acetabular components of the Zurich Cementless THR reflect different, both novel, approaches to addressing the most common complications of canine total hip replacement.

In 1999, after six years of clinical experience, Prof. Pierre M. Montavon, Head of Small Animal Surgery at the School of Veterinary Medicine, University of Zurich, and Slobodan Tepic, Dr. Sci., Dipl.Ing., of the AO Research Institute, Davos, Switzerland, with the participation and advice of Dr. Aldo Vezzoni, DVM, Dipl. ECVS, Cremona, Italy, initiated an international, multi-center clinical study, to collect well-documented, broad-based clinical performance data on the Zurich Cementless Total Hip Replacement. Data contributed by fourteen surgeons from eight countries on over 750 cases is in the final stages of preparation for publication. Collection of the surgical reports and clinical follow-up were coordinated by Prof. Randy Boudrieau, DVM, Dipl. ACVS, Prof. of Surgery, Cummings School of Veterinary Medicine, Tufts University, Massachusetts, USA.
read publications on the Zurich Cementless THR >>

By the end of 2009, the Zurich Cementless THR had been used in over 9,000 dogs by more than 150 surgeons in Europe, the United States, Australia, and Japan. KYON holds an exclusive, worldwide patent license in the veterinary field for the anchorage of the THR femoral component from SCYON Orthopaedics AG.

BIOLOGICAL BENEFITS:

  • Immediate and permanent proprietary locking-screw fixation
  • Near-physiolological loading of the proximal femur – absence of stress shielding
  • Full range of impingement free motion
  • Minimal disruption of methaphysial cancellous bone
  • Rapid bone ingrowth into a highly compliant acetabular cup
  • Absence of wear-particle induced lysis

TECHNICAL FEATURES:

  • Titanium and titanium alloy for supreme biocompatibility and reduced risk of infection
  • Titanium plasma porous coating for micro-interlock
  • Proprietary, hydraulically open, compliant, double shell metal backing for the cup
  • Amorphous Diamond Like Coating (ADLC) on the Head-Necks, harder, smoother, and more lubricious than conventional coatings, insuring superb articulation
  • Proprietary, wear-reducing geometry for the poly inlay

MEDICAL NEED

Hip dysplasia and osteoarthritis are leading causes for rear limb lameness. What are the consequences of hip dysplasia and what is the treatment history? read more>>

PRINCIPLES

The Zurich Cementless THR reduces the incidence of aseptic loosening compared with conventional THR systems. How? What is the rationale behind the Zurich Cementless THR? What are the benefits? read more>>

CLINICAL DEVELOPMENT

Kyon invented, developed, and introduced the Zurich Cementless THR procedure for total hip replacement in dogs. This technique was a major departure from conventional practice. What are the Zurich Cementless THR innovations and how did KYON bring this innovation to the veterinary community? read more>>
back to top Λ
Notes:
[1] – Annual Report 2007, The Swedish National Hip Arthroplasty Register, Dept. of Orthopaedics, Sahlgrenska University Hospital, February 2005, www.jru.orthop.gu.se